Eric Easom - 03 Nov 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
03 Nov 2022
Net transactions value
-$558,274
Form type
4
Filing time
07 Nov 2022, 19:19:13 UTC
Previous filing
02 Nov 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $173,683 -11,082 -28% $15.67 29,021 03 Nov 2022 Direct F1
transaction ANTX Common Stock Sale $49,376 -3,083 -11% $16.02 25,938 03 Nov 2022 Direct F1
transaction ANTX Common Stock Sale $139,474 -8,828 -34% $15.80 17,110 04 Nov 2022 Direct F1
transaction ANTX Common Stock Sale $161,705 -10,167 -59% $15.90 6,943 07 Nov 2022 Direct F1
transaction ANTX Common Stock Sale $34,036 -2,036 -29% $16.72 4,907 07 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.